An update on the management of refractory cutaneous lupus erythematosus

A Verdelli, A Corrà, EB Mariotti, C Aimo… - Frontiers in …, 2022 - frontiersin.org
Management of cutaneous lupus erythematosus (CLE) involves a combination of preventive
measures, topical and systemic drugs, fairly similar for the different subtypes. Although …

[PDF][PDF] First case presentation of refractory pediatric bullous lupus erythematosus (BSLE) treatment with belimumab.

HQ Zeng, XP Lu, ZB Yan, ZZ Ye - European Review for …, 2022 - europeanreview.org
INTRODUCTION: Bullous systemic lupus erythematosus (BSLE) is a rare form of
subcutaneous blistering lupus erythematosus (SLE). There is currently no effective treatment …

Refractory Bullous Systemic Lupus Erythematosus Successfully Treated with Rituximab: A Case Report and Literature Review

Y Ratanapokasatit, C Seree-Aphinan… - Clinical, Cosmetic …, 2023 - Taylor & Francis
Bullous systemic lupus erythematosus (BSLE) is a rare blistering skin manifestation of
systemic lupus erythematosus (SLE). Dapsone is reported to be helpful in mild-to-moderate …

Bullous systemic lupus erythematosus

D Lipsker - UpToDate [Internet]. Waltham (MA): UpToDate Inc, 2020 - uptodate.com
Bullous systemic lupus erythematosus (BSLE) is a rare autoimmune blistering disorder that
typically manifests as an acute vesiculobullous eruption in a patient with known systemic …

Rituximab en lupus sistémico ampolloso

M Cruz, DC Graña-Cruz, L Pérez… - Revista Española de …, 2020 - reccmi.com
El lupus eritematoso sistémico, es una enfermedad crónica autoinmune de compromiso
multiorgánico, infrecuente en el sexo masculino, donde se presenta con una mayor …